Article

OWL names Pamela Gleeson new president

Ophthalmic Women Leaders has appointed Pamela Gleeson, chief financial officer of Santen Inc., as its 2010 president. She previously served as chairwoman of the organization?s finance committee.



San Francisco

-Ophthalmic Women Leaders (OWL) has appointed Pamela Gleeson, chief financial officer (CFO) of Santen Inc., as its 2010 president. She previously served as chairwoman of the organization’s finance committee.

“With a deep understanding of the ophthalmic field, established relationships in the industry, and a strong commitment to mentoring future ophthalmic leaders, Pamela has already moved effortlessly into her role as president with plans for expanding our offerings,” said Molly Schar, executive director of OWL.

“I am thrilled to be serving as president and to be a part of an organization and mentoring program about which I’m very passionate,” said Gleeson. “Additionally, I am fortunate to work with one of OWL’s founding members, Santen CEO Adrienne Graves, who encouraged me to become involved with OWL in its early years.”

Gleeson joined Santen in 1997 and has served as its CFO since 2003. During her time with the company, she has held positions in business development, project management, new product development, and marketing. She also has served on the executive strategy committee. Before joining Santen, Gleeson held finance positions in the high-tech, mortgage banking services, and retail food industries after beginning her career at KPMG.

Related Videos
(Image credit: Ophthalmology Times) NeuroOp Guru: The role of muscle biopsy in heteroplasmy detection
(Image credit: Ophthalmology Times) AGS 2025: Achieving success as an academic ophthalmologist with Thomas V. Johnson III, MD, PhD
(Image credit: Ophthalmology Times) AGS 2025: Constance Okeke, MD, highlights 1-year Streamline canaloplasty outcomes
(Image credit: Ophthalmology Times) AGS 2025: Telemedicine and genetics for resource-efficient care with Louis R. Pasquale, MD
© 2025 MJH Life Sciences

All rights reserved.